Literature DB >> 8924064

Five-year mortality after acute myocardial infarction in relation to previous history, level of initial care, complications in hospital, and medication at discharge.

J Herlitz1, A Bång, M Sjölin, B W Karlson.   

Abstract

The purpose of this study was to describe the prognosis during 5 years of follow-up in a consecutive population of patients discharged from hospital after acute myocardial infarction (AMI) in relation to clinical history, level of initial care, complications during hospitalization, and medication at discharge. All patients admitted to a single hospital from February 15, 1986 to November 9, 1987 due to AMI, regardless of age and whether or not they were treated in the coronary care unit, and who were discharged alive from hospital were included in the study. There were 862 patients with AMI, 740 of whom were discharged alive. Information on medication at discharge was available in 713 patients (96%). In a multivariate analysis taking into account age, sex, history of cardiovascular diseases, whether patients were admitted to coronary care unit or not, complications during hospitalization, and medication at discharge, the following factors appeared to be independent predictors of mortality: age (p < 0.001), history of AMI (p < 0.001), congestive heart failure in hospital (p < 0.001), whether beta-blockers had been prescribed at discharge (p < 0.01), and a history of diabetes (p < 0.01). This study indicates that in consecutive patients surviving the hospital phase of AMI, the development of complications while in hospital and the manner in which medication was prescribed at discharge independently influenced their long-term prognosis, but age was the most important factor in long-term prognosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8924064     DOI: 10.1007/bf00051115

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  23 in total

1.  The effect of warfarin on mortality and reinfarction after myocardial infarction.

Authors:  P Smith; H Arnesen; I Holme
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

2.  Coronary prognostic index for predicting survival after recovery from acute myocardial infarction.

Authors:  R M Norris; D E Caughey; L W Deeming; C J Mercer; P J Scott
Journal:  Lancet       Date:  1970-09-05       Impact factor: 79.321

3.  Eligibility for intravenous thrombolysis in suspected acute myocardial infarction.

Authors:  B W Karlson; J Herlitz; N Edvardsson; H Emanuelsson; M Sjölin; A Hjalmarson
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

4.  Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group.

Authors: 
Journal:  Eur Heart J       Date:  1985-03       Impact factor: 29.983

5.  Prognosis and gender differences in chest pain patients discharged from an ED.

Authors:  J Herlitz; B W Karlson; I Wiklund; A Bengtson
Journal:  Am J Emerg Med       Date:  1995-03       Impact factor: 2.469

6.  Prognostic importance of digitalis after acute myocardial infarction.

Authors:  E B Madsen; E Gilpin; H Henning; S Ahnve; M LeWinter; J Mazur; R Shabetai; D Collins; J Ross
Journal:  J Am Coll Cardiol       Date:  1984-03       Impact factor: 24.094

7.  Prevalence and mortality of acute myocardial infarction in patients with diabetes.

Authors:  L Rytter; S Troelsen; H Beck-Nielsen
Journal:  Diabetes Care       Date:  1985 May-Jun       Impact factor: 19.112

8.  Risk factors and in-hospital course of first myocardial infarction in the elderly.

Authors:  K Robinson; R M Conroy; R Mulcahy
Journal:  Clin Cardiol       Date:  1988-08       Impact factor: 2.882

9.  Characteristics and prognosis of patients with acute myocardial infarction in relation to whether they were treated in the coronary care unit or in another ward.

Authors:  B W Karlson; J Herlitz; O Wiklund; P Pettersson; P Hallgren; A Hjalmarson
Journal:  Cardiology       Date:  1992       Impact factor: 1.869

10.  Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1986-07-12       Impact factor: 79.321

View more
  1 in total

1.  Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005.

Authors:  Tom Briffa; S Hickling; M Knuiman; M Hobbs; J Hung; F M Sanfilippo; K Jamrozik; P L Thompson
Journal:  BMJ       Date:  2009-01-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.